Vasopressin-induced presynaptic facilitation of sympathetic neurotransmission in the pithed rat

Journal of Hypertension

Volumn 20, Issue 6, 2002, Pages 1175-1180

  Streefkerk, Jörn O ^a   Mathy, Marie Jeanne ^a   Pfaffendorf, Martin ^a   Van Zwieten, Pieter A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Angiotensin; Pithed rat; Sympathetic nervous transmission; Vasopressin; Vasopressin antagonists

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DESMOPRESSIN; IRBESARTAN; NORADRENALIN; RELCOVAPTAN; SR 121463B; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ARGIPRESSIN; BIPHENYL DERIVATIVE; TETRAZOLE DERIVATIVE; VASOCONSTRICTOR AGENT;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; EXPERIMENTAL MODEL; FACILITATION; MALE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SPINAL ANIMAL; VASCULAR RESISTANCE; ANIMAL; BLOOD PRESSURE; DECEREBRATION; DIASTOLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; ELECTROSTIMULATION; PHYSIOLOGY; SYNAPTIC TRANSMISSION; SYNAPTOSOME; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; ARGININE VASOPRESSIN; BIPHENYL COMPOUNDS; BLOOD PRESSURE; DECEREBRATE STATE; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTRIC STIMULATION; MALE; NOREPINEPHRINE; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION; TETRAZOLES; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 0036591598     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200206000-00030     Document Type: Article

References (35)

1. Antidiuretic action of vasopressin: Quantitative aspects and interaction between V1a and V2 receptor-mediated effects
2. Vascular smooth muscle and neurohypophyseal Hormones
3. Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor
4. Vasodilation induced by a specific vasopressin V2 agonist in dogs
5. V2 receptor-mediated vasodilation in healthy humans
6. Aggregation of human blood platelets by vasopressin
7. 1-Deamino-8-D-arginine vasopressin: A new pharmacological approach to the management of haemophilia and von Willebrands' diseases
8. Regulation of pituitary ACTH secretion during chronic stress
9. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure
10. Increased plasma arginine vasopressin levels in patients with congestive heart failure
11. Role of vasopressin in essential hypertension: Racial differences
12. Vasopressin elevation in essential hypertension and increased responsiveness to sodium intake
13. Increased plasma vasopressin in low renin essential hypertension
14. Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention
15. Hormones and hemodynamics in heart failure
16. Changing role of the autonomic nervous system in human hypertension
17. The sympathetic nervous system in hypertension: A potential long-term regulator of arterial pressure
18. Arginine vasopressin enhances sympathetic constriction through the V1 vasopressin receptor in human saphenous vein
19. Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats
20. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist
21. Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1 a receptors
22. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist
23. Aquaretic and hormonal effects of a vasopressin V(2) receptor antagonist after acute and long-term treatment in rats
24. In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats
25. Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptor stimulation in pithed normotensive rats
26. Interactions between angiotensin II and alpha-adrenoceptor agonists mediating pressor responses in the pithed rat
27. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: A comparison between losartan, irbesartan, telmisartan, and captopril
28. Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats
29. Enhancement by vasopressin of adrenergic responses in human mesenteric arteries
30. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery
31. Effects of vasopressin on the sympathetic contraction of rabbit ear artery during cooling
32. Indications for vascular alpha- and beta-2 adrenoceptors in synapses of the muscarinic pathway in the pithed normotensive rat
33. Evidence for a sympatholytic effect of mibefradil in the pithed rat preparation
34. Vasopressin receptors involved in adrenergic neurotransmission in the circular muscle of the human vas deferens
35. Actions of vasopressin, oxytocin, and synthetic analogs on vascular smooth muscle